Corticosteroids and Immunomodulators for the treatment of dry eye
Review of artificial tears for dry eye
Communication between ODs and MDs for optimal care
General principles of treatment of dry eye disease
Standard testing and assessment for dry eye disease
Diagnosis and overlooking asymptomatic patients with dry eye
Epidemiology and consequences of untreated dry eye
Introduction and overview of dry eye
Novel vehicle contributes to cyclosporine efficacy
Study shows improvements in signs, symptoms after 3 months of treatment
Where to start with treating OSD patients
Cynthia Matossian, MD, FACS, advises on how ophthalmologists can start performing a better diagnosis of ocular surface disease in three simple steps.
Boosting short-term dry eye management in patients
Fast-acting efficacious options are key to treating acute inflammation
Evaluating and treating tear film patients with success
Cynthia Matossian, MD, FACS, explains why she believes if ophthalmologists consistently evaluate the ocular surface, tear film and lid margins—and treat any problems that we find—surgical outcomes will improve.
Examining ocular allergy, quality of life
Surveyed patients express dissatisfaction with efficacy of eye drops.
As cyclosporine options grow, focus remains on the vehicle
Amid a surge in dry eye cases since reopening her practice during the ongoing pandemic, Lisa Nijm, MD, JD, shares how cyclosporine, a well-established form of treatment, poses both challenges and advantages for ophthalmologists.
Artificial tears offer a path to contact lens comfort
Nanodrop technology improves lens comfort
2020 vision: The future of ophthalmology (Part III)
Susan Coultas, PhD, and Preeya Gupta, MD, share their hopes for continued innovation in the ophthalmic space — including dry eye and retina — as well as the importance of the clinical research process.
Kala’s dry eye treatment nears potential US launch before 2021
Susan Coultas, PhD, and Preeya Gupta, MD, discuss Kala Pharmaceuticals’ dry eye product candidate in a poster presentation during the 2020 Women in Ophthalmology virtual summer symposium.
Making dry eye manageable for patients working from home
One ophthalmologist offers insight on how to help patients treat their dry eye symptoms when working from home amid the pandemic.
New molecule for allergic conjunctivitis makes debut
First new therapy in nearly a decade offers another option for physicians, patients
The Technician’s Role
Role of the Technician
Lifitegrast Experience and Patient Counseling
Cyclosporine Formulation Challenges
Initiating Anti-Inflammatory/Immunomodulatory Therapy
Glaucoma Medications and Dry Eye Disease
Impact of Dry Eye on Surgical Outcome; Patient Screening
Dry Eye Disease Epidemiology
Patient Counseling on Generic vs. Branded
Cost and Substitution Issues
Generic vs. Branded Ophthalmic Medications
2 Clarke Drive Cranbury, NJ 08512